TherapeuticsMD To Present At JMP Securities Healthcare Conference
TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company
focused on developing and commercializing products targeted exclusively
for women, announced today that the Company will present at the JMP
TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women, announced today that the Company will present at the JMP Securities Healthcare Conference to be held July 9-10, 2013 at The St. Regis New York. Robert Finizio, Co-Founder and Chief Executive Officer, will present on Tuesday, July 9, 2013 at 4:30 p.m. Eastern Daylight Time. The presentation will also be available via a live audio webcast at the following link: http://wsw.com/webcast/jmp21/TXMD. Following the presentation, a replay will be available through TherapeuticsMD’s website at www.therapeuticsmd.com under the "Investor Relations" section and will remain available for 30 days after the presentation date. About TherapeuticsMD, Inc. TherapeuticsMD, Inc. is a women’s health pharmaceutical company driven to pursue the development and commercialization of advanced hormone replacement therapies. We are currently developing advanced hormone therapy pharmaceutical products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. We are evaluating various other potential indications for our hormone technology, including oral contraception, preterm birth, vulvar and vaginal atrophy, and premature ovarian failure. More information is available at www.therapeuticsmd.com. TherapeuticsMD ® is a registered trademark.